Device Week – November 6, 2016
On this week’s podcast, we discuss interventional cardiology devices and news out of TCT 2016, which recently wrapped up in Washington, DC. Also, FDA's public meeting on the MDUFA IV user-fee agreement.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.